As of March 24, 2020 the combined effort initially called the Greater Boston Consortium on Pathogen Readiness (GBCPR) became the Massachusetts Consortium on Pathogen Readiness (MassCPR).

Bringing together clinicians and scientists to develop and invest in both the research process and supporting infrastructure to address the current global COVID-19 pandemic, and better prepare for potential future outbreaks.

GBCPR Evergrande COVID-19 Response Fund Awards RFP

Key Dates

Request for Proposal Announced March 17, 2020
Proposals Due March 24, 2020
Funding Descision Announced April 2020
Anticipated Funding Start April 2020

Harvard Medical School (HMS) is now accepting applications for the Evergrande COVID-19 Response Fund Awards, available through the Greater Boston Consortium on Pathogen Readiness (GBCPR). Initial funding to support the Consortium has been generously provided to HMS by the China Evergrande Group.

For more information: link to RFP page.


Executive Director, Greater Boston Consortium on Pathogen Readiness

Harvard Medical School (HMS) seeks an experienced, creative, and effective administrator to make a major contribution to advancing a multipronged Boston-based Consortium to combat the global COVID-19 pandemic and future emerging pathogens. The position reports to the HMS Dean for Research Operations and Global Programs (DROGP) with a dotted-line relationship to the Faculty Co-Leaders of the Greater Boston Consortium on Pathogen Readiness (GBCPR). The Executive Director will work with the Faculty Co-Leaders and DROGP to build an organization whose objective is to create, invest in, and develop a research process and related infrastructure to address the current global COVID-19 pandemic and better position the Consortium for as yet unknown future outbreaks.
The initial efforts of the GBCPR are aimed at elucidating the basic biology of the SARS-CoV-2 virus and the pathogenesis of the resulting disease, developing new diagnostic tools, vaccines, and antiviral therapies, creating and using animal and other model systems, understanding disease epidemiology, and leveraging clinical expertise to improve medical management. The overarching collaboration is part of a five-year, $115 million research initiative funded by China Evergrande Group and it involves colleagues at the Guangzhou Institute of Respiratory Health in China.
The Executive Director is the administrative leader for program planning and development and works with the HMS Office for Research Operations to oversee the governance, finance, and management activities for the GBCPR. The Executive Director collaborates with the program’s Faculty Co-Leaders, Executive Committee (including the DROGP), Steering Committee, and Advisory Committee to provide general administrative direction and oversight for the GBCPR. The Executive Director oversees the practical implementation of all of the GBCPR’s logistical and administrative needs and ensures that the operations of the Consortium are functional and streamlined.

To learn more and apply: link to Harvard Careers